Surface ECG Mapping

Sponsor
Stanford University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04221958
Collaborator
(none)
5
1
10
0.5

Study Details

Study Description

Brief Summary

This study aims to confirm a scientific concept that superficially placed electrocardiogram (ECG) leads may be compared to one another to help determine positioning. If proven to be effective, this could offer a more non-invasive means of positioning using superficial ECG tracings.

Condition or Disease Intervention/Treatment Phase
  • Device: Electrocardiogram

Study Design

Study Type:
Observational
Anticipated Enrollment :
5 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Surface ECG Mapping in Healthy Adult Volunteers
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Nov 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Electrocardiogram (ECG) Mapping

Participants will have 10 superficial electrode-patches placed on their chest in two vertical columns of 5 electrode-patches. The channels V1-V5 will be connected to one of the columns. The channel V6 will be connected to each of the electrode-patches in the second column ad recordings will be taken for approximately 2 minutes on each electrode-patch. ECG readings will be recorded.

Device: Electrocardiogram
An electrocardiogram measures the electrical activity of the heartbeat. This "intervention" will be used on healthy adult volunteers whom are part of the staff at the institution.

Outcome Measures

Primary Outcome Measures

  1. ECG Tracing [Approximately 30 minutes]

    ECG tracing for each electrode will be recorded in voltage per unit of time.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult volunteers from institution's staff

  • Age >18 years

Exclusion Criteria:
  • Existing heart conditions

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford Health Care Stanford California United States 94305

Sponsors and Collaborators

  • Stanford University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chi-Ho Ban Tsui, Professor-Med Ctr Line, Stanford University
ClinicalTrials.gov Identifier:
NCT04221958
Other Study ID Numbers:
  • 54619
First Posted:
Jan 9, 2020
Last Update Posted:
Jul 25, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No

Study Results

No Results Posted as of Jul 25, 2022